[
  {
    "ts": null,
    "headline": "Why Becton Dickinson (BDX) is a Top Momentum Stock for the Long-Term",
    "summary": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.",
    "url": "https://finnhub.io/api/news?id=0b000f0c5386a351a86e0c64d1c283513ca86db8ff0ee54b374cf311f72d889e",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734447012,
      "headline": "Why Becton Dickinson (BDX) is a Top Momentum Stock for the Long-Term",
      "id": 132026666,
      "image": "https://media.zenfs.com/en/zacks.com/7853de8d69faeccb7d1ad6ebba40b8a2",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.",
      "url": "https://finnhub.io/api/news?id=0b000f0c5386a351a86e0c64d1c283513ca86db8ff0ee54b374cf311f72d889e"
    }
  },
  {
    "ts": null,
    "headline": "BD and Babson Diagnostics Launch Innovative Fingertip Blood Testing to Health Care Organizations",
    "summary": "BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Babson Diagnostics, a science-first health care technology company, today announced an expansion of fingertip blood collection and testing technologies for use by U.S. health systems and other large provider networks in settings like urgent cares, doctor offices and other ambulatory care settings.",
    "url": "https://finnhub.io/api/news?id=87a01b89a1561acc71a5381921e43702916dfb8c7de4086d2e51a82f95f1a5c4",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734436200,
      "headline": "BD and Babson Diagnostics Launch Innovative Fingertip Blood Testing to Health Care Organizations",
      "id": 132025015,
      "image": "https://media.zenfs.com/en/prnewswire.com/c599b4ccf48235fd0756a2a3df4c0c97",
      "related": "BDX",
      "source": "Yahoo",
      "summary": "BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Babson Diagnostics, a science-first health care technology company, today announced an expansion of fingertip blood collection and testing technologies for use by U.S. health systems and other large provider networks in settings like urgent cares, doctor offices and other ambulatory care settings.",
      "url": "https://finnhub.io/api/news?id=87a01b89a1561acc71a5381921e43702916dfb8c7de4086d2e51a82f95f1a5c4"
    }
  },
  {
    "ts": null,
    "headline": "Becton Dickinson to Pay $175 Million for Misleading Investors About Alaris Infusion Pump",
    "summary": "* New Jersey-based company will also retain independent compliance consultantWashington D.C. - The Securities and Exchange Commission today announced settled charges against Becton, Dickinson and...",
    "url": "https://finnhub.io/api/news?id=17d1d010f28687499f1f72e048339e1b6b326b7390f82a03794002aa618b4383",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1734410946,
      "headline": "Becton Dickinson to Pay $175 Million for Misleading Investors About Alaris Infusion Pump",
      "id": 132022299,
      "image": "",
      "related": "BDX",
      "source": "Finnhub",
      "summary": "* New Jersey-based company will also retain independent compliance consultantWashington D.C. - The Securities and Exchange Commission today announced settled charges against Becton, Dickinson and...",
      "url": "https://finnhub.io/api/news?id=17d1d010f28687499f1f72e048339e1b6b326b7390f82a03794002aa618b4383"
    }
  }
]